Researchers develop new technology to accelerate slow venous injection

US researchers have developed a new technology that may enable the rapid injection of medicines that currently need a slow plot. Patient injections are known to be known as antibody medicine, usually used to treat cancer, auto -immune diseases and metabolic disorders, to a large amount of fluid, which means that the need to undergo a venous distillation that lasts long, because antibodies, which are protein, remain stable in fluids with low concentrations. In the study published by the Transitional Medicine Sciences and Stanfor University, the researchers said that there is a new way to pack proteins through which they can be stored with high concentrations to provide patients with regular sprayers or a self -injury. And so that the researchers can place the protein in fluid with high concentrations while retaining their stability and effectiveness, covering the small particles with a substance called (MONI). The researchers said that the layer used in packaging prevents particles from melting or sticking to each other and keeping it dry and stable. “We have achieved something similar to chocolate covered with sweets, where the protein is inside and our polymer is a solid glass layer from the outside,” Eric Abel, from Stanford University, said in a statement. In the tests performed with 3 different proteins, the albumin, the human immunotherapy and the monochromatic body to treat corona, the researchers were able to inject a solution with more than gay concentration of ordinary injection fluids. Abel explained that the new method is “likely to work with any biological medication so we can easily inject it.” He added: “It transmits these treatments from an ordeal that takes a few hours into the clinic with venous injection to something that can be done in a few seconds using a self -insintion at home.”